| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/15/2007 | US20070060515 Epithelial cell specific growth factor keratinocyte growth factor (KGF) |
| 03/15/2007 | US20070059825 Cytokine zalpha11 ligand antibodies |
| 03/15/2007 | US20070059810 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 03/15/2007 | US20070059808 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection |
| 03/15/2007 | US20070059807 Mucosal immunization to prevent prion infection |
| 03/15/2007 | US20070059804 polynucleotides that code cysteine mutant proteins that bind to their cognate receptor or exhibit antiviral activity |
| 03/15/2007 | US20070059803 Mammalian cytokines; related reagents and methods |
| 03/15/2007 | US20070059800 Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 03/15/2007 | US20070059799 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 03/15/2007 | US20070059798 Polypeptides useful for molecular weight determinations |
| 03/15/2007 | US20070059797 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell |
| 03/15/2007 | US20070059796 Binding motif and methods of regulating cell function |
| 03/15/2007 | US20070059795 Engineered zinc finger proteins for regulation of gene expression |
| 03/15/2007 | US20070059794 Chaperonin-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release formulation, and method of producing antibody against target protein |
| 03/15/2007 | US20070059793 Nogo receptor binding protein |
| 03/15/2007 | US20070059792 convergent assembly of a plurality of pairs of oligopeptides; stable C-terminal disulfide-protected carboxythioester group that can be deprotected to spontaneously generate a free C-terminal thioester; allows a single precursor to participate in a succession of chemical ligation reactions |
| 03/15/2007 | US20070059791 Preparation of vaccines using a photosensitizer and light |
| 03/15/2007 | US20070059776 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry |
| 03/15/2007 | US20070059772 Phosphorylated glyoxalase I and its use |
| 03/15/2007 | US20070059767 Method of identifying N-terminal proBNP |
| 03/15/2007 | US20070059766 Mixture of binding proteins |
| 03/15/2007 | US20070059759 Human T2R63 receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070059758 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding |
| 03/15/2007 | US20070059756 Immunointeractive molecules and their uses in treating subjects suffering from Hev b 5 allergies |
| 03/15/2007 | US20070059744 Corynebacterium glutamicum genes encoding novel proteins |
| 03/15/2007 | US20070059730 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 03/15/2007 | US20070059729 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer |
| 03/15/2007 | US20070059725 Apparatus and method for detecting microscopic organisms using bacteriophage |
| 03/15/2007 | US20070059723 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 03/15/2007 | US20070059721 MAGI polynucleotides, polypeptides, and antibodies |
| 03/15/2007 | US20070059718 Systems and methods for enrichment of analytes |
| 03/15/2007 | US20070059713 SSB-DNA polymerase fusion proteins |
| 03/15/2007 | US20070059702 Disease related protein network |
| 03/15/2007 | US20070059699 Methods for detecting toxic and non-toxic cyanobacteria |
| 03/15/2007 | US20070059698 Marks as modifers of the pten pathway and methods of use |
| 03/15/2007 | US20070059689 Hybrid glycosylated products and their production and use |
| 03/15/2007 | US20070059688 Gastrointestinal chemosensory receptors |
| 03/15/2007 | US20070059309 Culturing a host cell transformed with a nucleic acid encoding murine anti-human IFN- alpha monoclonal antibody 9F3; culture product neutralizes all seven of recombinant human IFN- alpha subtypes tested; diseases involving cell overexpression; autoimmune diseases; antidiabetic agents; lupus (SLE) |
| 03/15/2007 | US20070059308 efficient, high throughput screening of antibody libraries against proteins targets; for screening a diverse antibody library for antibodies that bind to a membrane protein such as a chemokine receptor in yeast |
| 03/15/2007 | US20070059307 Biological products |
| 03/15/2007 | US20070059305 Neutralizing human anti-IGFR antibody |
| 03/15/2007 | US20070059303 monoclonal antibody for prevention and treatment of allergies, asthma, crohn's and lymes disease, arthritis, diabetes, glomerularnephritis, vision defects, skin disorders, sarcoidosis and viral diseases |
| 03/15/2007 | US20070059283 Feline IL-18 nucleic acid molecules |
| 03/15/2007 | US20070059282 Immunocytokine sequences and uses thereof |
| 03/15/2007 | US20070059241 neutralizing monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1); anticancer agent |
| 03/15/2007 | CA2621973A1 Chimeric hcn channels |
| 03/15/2007 | CA2621414A1 Mmp-7 and adf derived tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules |
| 03/14/2007 | EP1762623A1 Methods for producing biologically active peptide dimers |
| 03/14/2007 | EP1762610A1 Truncated dance, dance complex and method of using these |
| 03/14/2007 | EP1761561A2 Antibody specificity transfer using minimal essential binding determinants |
| 03/14/2007 | EP1504098B1 A method for in vitro molecular evolution of protein function |
| 03/14/2007 | EP1325956B1 Plant lesion formation suppressing gene, spl7 and use theriof |
| 03/14/2007 | EP1305434B1 A human disintegrin protein |
| 03/14/2007 | EP1254180B1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
| 03/14/2007 | EP1226169B1 Molecular structure of rhd negative locus |
| 03/14/2007 | EP1112351B1 Polymerase chimeras |
| 03/14/2007 | EP1098979B1 Antibody with improved producibility |
| 03/14/2007 | EP0698089B1 Nucleic acid encoding amp-activated protein kinase |
| 03/14/2007 | CN1930294A Cellulase fusion protein and heterologous cellulase fusion construct encoding the same |
| 03/14/2007 | CN1930288A Cells of which genome is modified |
| 03/14/2007 | CN1930287A Process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 03/14/2007 | CN1930187A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 03/14/2007 | CN1930186A Media for clostridium bacterium and processes for obtaining a clostridial toxin |
| 03/14/2007 | CN1928109A Preparation method of natural multi-component antibacterial protein fermentation liquor |
| 03/14/2007 | CN1928096A Method of producing recombination hirudin in transgene soybean with oil body protein as carrier |
| 03/14/2007 | CN1928080A Mixing microcapsule of sodium alginate and pancreatic enzymes, preparation and application thereof |
| 03/14/2007 | CN1927137A Pre-transplant accommodated organs resistant to anti-donor immunity |
| 03/14/2007 | CN1304592C Method of deamidation of milk protein and method of denaturation of milk protein |
| 03/14/2007 | CN1304568C Novel human complement C1r-like serine proteinase analogue, and its encoding sequence and use |
| 03/14/2007 | CN1304411C Saltant dihydrofolic acid reductase gene and application in mammal cell gene expression thereof |
| 03/14/2007 | CN1304410C Tumor necrosis factor-Gamma |
| 03/13/2007 | US7189839 An isolated polynucleotide that encodes a polypeptide comprising an amino acid sequence that represents the extracellular domain, also called a cytokine-binding domain, of a new human soluble class II cytokine receptor designated Zcytor16; antiarthritic and -inflammatory agents; autoimmune diseases |
| 03/13/2007 | US7189838 PRO9834 nucleic acids |
| 03/13/2007 | US7189830 Anti-KSA/IL-2 fusion proteins with reduced immunogenicity |
| 03/13/2007 | US7189827 Fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides; recombinant proteins |
| 03/13/2007 | US7189825 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents; immunotherapy |
| 03/13/2007 | US7189824 Monoclonal antibody which recognizes an antigen on the surface of tumor vessel endothelial cells; conjugates with diagnostic, chemotherapeutic agents for diagnosis or treatment of tumors |
| 03/13/2007 | US7189823 Monoclonal antibody useful in the diagnosis of proliferative disorders of the colon such as colon cancer; ILLFDYFNR is a colon cancer antigen sequence |
| 03/13/2007 | US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases |
| 03/13/2007 | US7189819 Humanized antibodies that recognize beta amyloid peptide |
| 03/13/2007 | US7189817 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2007 | US7189813 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 03/13/2007 | US7189811 Process for solubilization of recombinant proteins expressed as inclusion body |
| 03/13/2007 | US7189810 Polypeptides, use thereof and process for producing the same |
| 03/13/2007 | US7189809 Genetic engineered ioslated polynucleotide; anticholesterol agents, Alzheimer's disease, antilipemic agents |
| 03/13/2007 | US7189807 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 03/13/2007 | US7189803 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2007 | US7189689 Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders |
| 03/13/2007 | US7189566 Nucleotide sequences coding polypeptide for use in the treatment of bone, arthritic, inflammatory, fertility and atherosclerotic disorders |
| 03/13/2007 | US7189559 Nucleic acid; alters quantity of oil in bacteria, yeast such as Yarrowia, algae and fungi; genetic engineering |
| 03/13/2007 | US7189552 Thermostable alpha-amylases |
| 03/13/2007 | US7189546 Polypeptide, cDNA encoding the same, and use of them |
| 03/13/2007 | US7189541 Botulinum toxin production method |
| 03/13/2007 | US7189540 Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proteins |
| 03/13/2007 | US7189539 Polypeptides, fragments and homologues; vectors, host cells, antibodies; genetic engineering and expression; treatment of urogenital, sexual, metabolic, inflammatory, pregnancy, and g-protein coupled receptor disorders; drug screening |
| 03/13/2007 | US7189538 Comprises polypeptide associated with hyphal branching for use in controlling hyphal morphology and fungal viscosity/propagation in culture; heterologous gene expression and bioreactors |
| 03/13/2007 | US7189537 Comprises oncogenic nucleotide sequences for use in diagnosis, prevention and treatment of various cancers; gene therapy and antisense agents |
| 03/13/2007 | US7189536 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus |
| 03/13/2007 | US7189535 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 03/13/2007 | US7189532 PRO polypeptides; fusion proteins |